Supervised mutational signatures for obesity and other tissue-specific etiological factors in cancer
暂无分享,去创建一个
Alexander V. Favorov | L. Cope | K. Kinzler | B. Vogelstein | Bahman Afsari | L. Danilova | Lu Li | C. Tomasetti | A. Grollman | T. Rosenquist | Yifan Zhang | Albert Kuo | Kamel Lahouel
[1] Forrest W. Crawford,et al. Using sigLASSO to optimize cancer mutation signatures jointly with sampling likelihood , 2020, Nature Communications.
[2] C. Tomasetti. Mutated clones are the new normal , 2019, Science.
[3] W. Willett,et al. Cancer prevention: Molecular and epidemiologic consensus , 2018, Science.
[4] R. Durrett,et al. Role of stem-cell divisions in cancer risk , 2017, Nature.
[5] B. Vogelstein,et al. Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention , 2017, Science.
[6] Hans Clevers,et al. Tissue-specific mutation accumulation in human adult stem cells during life , 2016, Nature.
[7] Isidro Cortes-Ciriano,et al. The Impact of Environmental and Endogenous Damage on Somatic Mutation Load in Human Skin Fibroblasts , 2016, PLoS genetics.
[8] E. Giovannucci,et al. Preventable Incidence and Mortality of Carcinoma Associated With Lifestyle Factors Among White Adults in the United States. , 2016, JAMA oncology.
[9] J. Manson,et al. Determinants and Consequences of Obesity. , 2016, American journal of public health.
[10] M. Stratton,et al. Mutational signatures associated with tobacco smoking in human cancer , 2016, Science.
[11] G. Parmigiani,et al. Familial Risk and Heritability of Cancer Among Twins in Nordic Countries. , 2016, JAMA.
[12] M. Stratton,et al. Clock-like mutational processes in human somatic cells , 2015, Nature Genetics.
[13] D. Sahoo,et al. CD14-expressing cancer cells establish the inflammatory and proliferative tumor microenvironment in bladder cancer , 2015, Proceedings of the National Academy of Sciences.
[14] A. Morris,et al. Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions , 2015, BDJ.
[15] Paz Polak,et al. Cell-of-origin chromatin organization shapes the mutational landscape of cancer , 2015, Nature.
[16] B. Vogelstein,et al. Variation in cancer risk among tissues can be explained by the number of stem cell divisions , 2015, Science.
[17] David T. W. Jones,et al. Signatures of mutational processes in human cancer , 2013, Nature.
[18] K. Kinzler,et al. Mutational Signature of Aristolochic Acid Exposure as Revealed by Whole-Exome Sequencing , 2013, Science Translational Medicine.
[19] P. A. Futreal,et al. Genome-Wide Mutational Signatures of Aristolochic Acid and Its Application as a Screening Tool , 2013, Science Translational Medicine.
[20] M. Stratton,et al. Deciphering Signatures of Mutational Processes Operative in Human Cancer , 2013, Cell reports.
[21] Giovanni Parmigiani,et al. Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation , 2013, Proceedings of the National Academy of Sciences.
[22] Li Ding,et al. Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers , 2012, Cell.
[23] Angela N. Brooks,et al. Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing , 2012, Cell.
[24] G. Cumming,et al. Smoking and the Lung , 2011 .
[25] Kenneth Offit,et al. Genome-wide association studies of cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] Gina Lee,et al. Smoking and lung cancer: the role of inflammation. , 2008, Proceedings of the American Thoracic Society.
[27] Eric R. Ziegel,et al. The Elements of Statistical Learning , 2003, Technometrics.
[28] P. Hainaut,et al. Patterns of p53 G-->T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke. , 2001, Carcinogenesis.
[29] H. Sebastian Seung,et al. Learning the parts of objects by non-negative matrix factorization , 1999, Nature.
[30] W. Peng,et al. Accelerated deamination of cytosine residues in UV-induced cyclobutane pyrimidine dimers leads to CC-->TT transitions. , 1996, Biochemistry.
[31] J. Essigmann,et al. Mutational properties of the primary aflatoxin B1-DNA adduct. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[32] G A Colditz,et al. Physical Activity, Obesity, and Risk for Colon Cancer and Adenoma in Men , 1995, Annals of Internal Medicine.
[33] G. Pfeifer. Mutagenesis at methylated CpG sequences. , 2006, Current topics in microbiology and immunology.